Parathyroid Neoplasms

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

EMA approval · 2024-06-06
EMA Authorised: Mimpara (cinacalcet hydrochloride) — Amgen Europe B.V.
The European Medicines Agency authorised Mimpara (cinacalcet hydrochloride) for indications including hypercalcemia, parathyroid neoplasms, …